Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study Using Genomic Screening to Select Patients for Targeted Molecular Treatment

NCT02290522 is registered in ClinicalTrials.gov with Ulrik Lassen as lead sponsor.

NCT NCT02290522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02290522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study Using Genomic Screening to Select Patients for Targeted Molecular Treatment
Lead sponsor
Ulrik Lassen
Phase
Not applicable
Overall status
Recruiting
Start date
May 1, 2013
Completion date
December 31, 2029
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

unspecified adult solid tumor, protocol specific